About CELLINK
CELLINK is a company based in Boston (United States) founded in 2016. CELLINK has completed 8 acquisitions, including Cytena, Dispendix and Echo Laboratories. CELLINK operates in a competitive market with competitors including Nuclera Nucleics, Aspect Biosystems, Collplant, ROKIT Healthcare and Triastek, among others.
- Headquarter Boston, United States
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$323.15 M (USD), Post-IPO
Mar 11, 2021
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Cytena
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CELLINK
Unlock access to complete
Sales and Marketing
10 people
Software Development Team
5 people
Human Resources and Administration
4 people
Finance and Accounting
4 people
Product Management Team
3 people
Senior Team
2 people
Leadership Team
2 people
Global Team
1 people
Unlock access to complete
Funding Insights of CELLINK
Investors in CELLINK
CELLINK has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for CELLINK
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CELLINK
CELLINK has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Cytena, Dispendix and Echo Laboratories.
Investment portfolio details for CELLINK
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Non-contact nanoliter dispensing technology is developed and offered.
|
Locked | Locked | 2015 | Locked | |
|
Single cells are isolated using the cy-Clone device technology.
|
Locked | Locked | 2014 | Locked | |
|
Hybrid optical microscope
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for CELLINK
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CELLINK
Detailed financials for CELLINK
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellink Comparisons
Peer comparison for CELLINK
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CELLINK
CELLINK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Aspect Biosystems, Collplant, ROKIT Healthcare and Triastek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| Locked | Locked | Locked |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| Locked | Locked | Locked |
4D bio-printer solutions for tissue regeneration are provided.
|
|
| Locked | Locked | Locked |
Provider of 3D printing pharmaceutical technology platform for drug design
|
Detailed competitors of CELLINK
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellink
Complete news archive for CELLINK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CELLINK
CELLINK was founded in 2016.
CELLINK is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
CELLINK was founded in 2016 in Boston, United States, within the biotechnology sector. 3D bioprinters are designed and developed for applications in cell culture, tissue engineering, and drug development. Bioinks, single-cell dispensers, liquid handlers, bioreactors, live-cell analyzers, omics tools, NGS reagents, biomaterials, and various consumables are also provided to support research operations.
CELLINK's top competitors include Nuclera Nucleics, Aspect Biosystems and Allevi.
CELLINK has made 8 acquisitions, including Cytena, Dispendix, and Echo Laboratories.
CELLINK has 1 investor. Key investors include European Union.